Clementia enrols children in ongoing Phase II trial of palovarotene to treat FOP
An additional clinical trial site has been added by the company in the UK to ease travel burden for affected individuals living in the European Union (EU). FOP
Biointron Biological has launched RushData, a new platform to support the process of antibody discovery for pharmaceutical and biotechnology companies employing AI and machine learning (ML).
The grant will allow the company to progress OCD155 through pre-clinical development towards clinical trials and to further unravel the mechanism-of-action, which will be done in a Dutch-Danish-German-Swiss
The new formula is comprised of clinically proven ingredients for immune protection including: EpiCor, a specialized yeast fermentate, Lactobacillus GG, the number one studied probiotic strain backed by